HFM
IOVA icon

Harvest Fund Management’s Iovance Biotherapeutics IOVA Stock Holding History

Harvest Fund Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,208
Closed -$62K – 684
2024
Q1 		$62K Buy
+4,208
New +$49K 0.01% 484
2021
Q4 		– Sell
-297
Closed -$7K – 793
2021
Q3 		$7K Hold
297
– – ﹤0.01% 714
2021
Q2 		$7K Hold
297
– – ﹤0.01% 735
2021
Q1 		$9K Buy
+297
New +$12.3K ﹤0.01% 758
2020
Q2 		– Sell
-1,892
Closed -$56K – 482
2020
Q1 		$56K Buy
+1,892
New +$50.2K 0.01% 281

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Harvest Fund Management's IOVA Position: Q2 2024 in Review

Harvest Fund Management sold out of Iovance Biotherapeutics (IOVA) in Q2 2024, closing a stake of 4,208 shares — an estimated $62K sold.

Harvest Fund Management first reported a position in IOVA in Q1 2020 and held it in 5 quarters. The position peaked at $62K in Q1 2024. 295 funds tracked by Wall St. Rank hold IOVA as of Q2 2024.

  • Harvest Fund Management reported no remaining Iovance Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Harvest Fund Management sold 4,208 Iovance Biotherapeutics shares in Q2 2024, an estimated $62K.
  • Harvest Fund Management first reported a position in Iovance Biotherapeutics in Q1 2020 and held it in 5 quarters.
  • Harvest Fund Management's Iovance Biotherapeutics position peaked at $62K in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2024.

Based on Harvest Fund Management's 13F filing for Q2 2024, filed 8 Aug 2024.